Literature DB >> 32702512

The impacts of private hospital entry on the public market for elective care in England.

Elaine Kelly1, George Stoye2.   

Abstract

This paper examines reforms that enabled private hospitals to compete with public hospitals for elective patients in England. Studying hip replacements, we compare changes in outcomes across areas differentially exposed to private hospital entry, instrumenting hospital entry with the pre-reform location of private hospitals. We find private hospital entry increased the number of publicly funded hip replacements by 12% but did not reduce volumes at incumbent public hospitals, and had no impact on readmission rates. This suggests new entrants exerted little competitive pressure on incumbents. Instead, the market expanded with more marginal patients receiving treatment at an earlier point in time, resulting in a fall in average patient severity. Additional publicly funded volumes were not associated with reduced privately funded volumes, while impacts of provider entry did not vary by local deprivation. These findings indicate the reform increased publicly funded capacity but did not improve quality at existing public hospitals.
Copyright © 2020 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hospital competition; Independent Sector Providers; Market entry; Private provision

Year:  2020        PMID: 32702512     DOI: 10.1016/j.jhealeco.2020.102353

Source DB:  PubMed          Journal:  J Health Econ        ISSN: 0167-6296            Impact factor:   3.883


  2 in total

1.  Emergency contracting and the delivery of elective care services across the English National Health Service and independent sector during COVID-19: a descriptive analysis.

Authors:  Rocco Friebel; Jon Fistein; Laia Maynou; Michael Anderson
Journal:  BMJ Open       Date:  2022-07-18       Impact factor: 3.006

2.  Divided by choice? For-profit providers, patient choice and mechanisms of patient sorting in the English National Health Service.

Authors:  Walter Beckert; Elaine Kelly
Journal:  Health Econ       Date:  2021-02-05       Impact factor: 3.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.